Dr. Aubrey de Grey
SENS, Co-Founder and CSO
SENS, Chief Science Officer and Co-founder, Dr. de Grey is the biomedical gerontologist who researched the idea for and founded SENS Research Foundation. He received his BA in Computer Science and Ph.D. in Biology from the University of Cambridge in 1985 and 2000, respectively.
Dr. de Grey is Editor-in-Chief of Rejuvenation Research, is a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the editorial and scientific advisory boards of numerous journals and organizations.
Why therapies that can add 30 healthy years to the remaining lifespan of typical 60-year-olds may well arrive within the next few decades.
It may seem premature to be discussing the comprehensive medical conquest of human aging when so little progress has yet been made in even postponing it. However, two facts undermine this assessment. Firstly, aging happens throughout our lives but only causes ill-health after middle age: this shows that we can postpone that ill-health without knowing how to prevent aging completely, but instead by molecular and cellular repair Secondly, regenerative medicine is now advancing from a futuristic twinkle in a few visionaries' eyes to a realistic strategy for addressing numerous medical conditions. I will explain why therapies that can add 30 healthy years to the remaining lifespan of typical 60-year-olds may well arrive within the next few decades.